📝 Sheel Biotech Limited — results explained
Quarter ended September 2025 (Q2 FY26)
Sheel Biotech Limited reported revenue of ₹22 crore for the quarter ended September 2025 (Q2 FY26).
Net profit stood at ₹0 crore. Earnings per share (EPS) came in at ₹0.13.
Operating profit stood at ₹2 crore — an operating margin (OPM) of 8.1%.